Please try another search
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company’s lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Name | Age | Since | Title |
---|---|---|---|
Fred E. Cohen | 68 | 2017 | Independent Director |
Cynthia Marie Butitta | 70 | 2017 | Independent Director |
Fred Witjes | - | - | Member of Scientific Advisory Board |
Arie S. Belldegrun | 75 | 2012 | Independent Chairman |
Jack Baniel | - | - | Member of Scientific Advisory Board |
Herbert Lepor | - | - | Chairman of Scientific Advisory Board |
Stuart Holden | 81 | 2015 | Independent Director |
Leana S. Wen | 41 | 2022 | Independent Director |
Elizabeth A. Barrett | 62 | 2019 | President, CEO & Director |
Daniel Wildman | 67 | 2022 | Independent Director |
James A. Robinson | 54 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review